| Amlodipine - Wikipedia, the free encyclopedia Amlodipine (Norvasc (Pfizer) and generics) (as besylate, mesylate or maleate) is a long-acting calcium channel blocker (dihydropyridine (DHP) class) used as an anti ... Read More |
| Amlodin - definition of Amlodin in the Medical dictionary - by the ... amlodipine /am·lo·di·pine/ (am-lo´dĭ-pēn″) a calcium channel blocking agent used as the besylate salt in the treatment of hypertension and chronic stable and ... Read More |
| Amlodin - Drugs.com Amlodin is a medicine available in a number of countries worldwide. A list of US medications equivalent to Amlodin is available on the Drugs.com website. Read More |
| New OD tablet of AMLODIN® by original formulation technology ... News Releases of Dainippon Sumitomo Pharma is introduced. ... Dainippon Sumitomo Pharma Co., Ltd. (Headquarters: Osaka, Japan; President: Masayo Tada) announces that ... Read More |
| Amlodin - Ask Your Questions on Amlodin - Healthsofa.com Amlodin • Read Experiences, Ask Questions and Exchange Thoughts on Amlodin - 100% Free. 100% Helpful. Read More |
| Kleva - Products - By Product Amlodipine, the active ingredient of AMLODIN, belongs to Ca2+ channel antagonists. It is administered for the reduction of arterial pressure and for the treatment of ... Read More |
| Dainippon Sum.Pharma : Dainippon Sumitomo Pharma Submits ... Dainippon Sum.Pharma : Dainippon Sumitomo Pharma Submits Application Based on Public Knowledge for long-acting calcium antagonist AMLODIN tablets/OD tablets for the ... Read More |
| List of bestselling drugs - Wikipedia, the free encyclopedia Amlodin: Amlodipine: 506: 4%: Dainippon Sumitomo: Hypertension, angina pectoris: n/a: Mon-20XX: 185: Niaspan: Niacin: 498: 13%: Kos Pharmaceuticals: Cholesterol: Jul-1997: Mon-20XX Read More |
| Amlodipine Tablets 5mg, 10mg - X-PIL Patient Information Leaflet: Amlodipine Tablets 5mg, 10mg - X-PIL Read More |
| Status Quo Restored, as Pfizer and Dainippon Sumitomo Settle ... Japan: 2 November 2005: Sumitomo Launches Counter-Attack against Pfizer in Amlodin Dispute; Japan: 17 October 2005: Licensing Dispute with Pfizer over Amlodipine Darkens ... Read More |
